Covaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...

Earlier in the week, NITI Aayog's Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DC...

The efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization deliberated upon Hyderabad-based Bharat Biotech...

“The tireless efforts of our scientists at ICMR and BBIL have resulted in a truly effective international vaccine of the highest standards ...

Congress-ruled Chhattisgarh would deploy the vaccine in government medical colleges and government hospitals from Monday.

After more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinic...

The drug regulator’s subject expert committee (SEC) will meet on Thursday to consider the vaccine maker’s request and review the data. “The...

The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...

Covaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...

Bharat Biotech, makers of India's first indigenous vaccine for Covid-19, has advised people not to take 'Covaxin' if they have allergies, f...

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vacci...

A day before India begins the world’s largest Covid-19 vaccination drive, a group of healthcare-focused NGOs has sought clarifications from...

In the letters addressed to the PM and Union Health Minister Harsh Vardhan, these NGOs have also sought punishment for the "responsible par...

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the countrys first an...

"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...

“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...